Towards Non-invasive and Personalized Management of Breast Cancer Patients from Multiparametric MRI via A Large Mixture-of-Modality-Experts Model

Read original: arXiv:2408.12606 - Published 9/4/2024 by Luyang Luo, Mingxiang Wu, Mei Li, Yi Xin, Qiong Wang, Varut Vardhanabhuti, Winnie CW Chu, Zhenhui Li, Juan Zhou, Pranav Rajpurkar and 1 other
Total Score

0

Towards Non-invasive and Personalized Management of Breast Cancer Patients from Multiparametric MRI via A Large Mixture-of-Modality-Experts Model

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • This paper describes a large machine learning model that uses a mixture of experts to diagnose breast cancer from multiparametric MRI data.
  • The model combines different neural network experts, each focused on a specific MRI modality, to make a final diagnosis.
  • This approach aims to leverage the complementary information from multiple MRI sequences to improve diagnostic performance.

Plain English Explanation

Diagnosing breast cancer can be a complex task, as it often requires analyzing various medical imaging scans like MRI. This research paper presents a new machine learning model that is designed to make this process more accurate.

The key idea is to use a mixture of specialized "expert" models, each focusing on a different type of MRI data. For example, one expert might analyze the contrast-enhanced images, while another focuses on the diffusion-weighted images. By combining the insights from these different experts, the overall model can make a more informed diagnosis.

The researchers trained this large, multi-expert model on a diverse dataset of breast MRI scans. They found that this approach outperformed simpler, single-model approaches, demonstrating the value of leveraging complementary information from various MRI modalities. This builds on previous work exploring the use of AI for breast cancer diagnosis from medical imaging.

Technical Explanation

The researchers developed a large machine learning model with a mixture of modality-specific experts to diagnose breast cancer from multiparametric MRI data. The model architecture consists of several neural network experts, each focused on a particular MRI sequence (e.g., T1-weighted, T2-weighted, diffusion-weighted).

These expert models are trained independently on their respective MRI modalities, allowing them to develop specialized feature representations. The outputs from the experts are then combined using a gating network, which learns to weigh the contributions of each expert based on the input data. This mixture-of-experts approach enables the model to leverage the complementary information from the different MRI sequences.

The researchers evaluated their model on a large, multi-center dataset of breast MRI scans. They compared the performance of the mixture-of-experts model to simpler, single-model approaches and found that it achieved significantly higher accuracy in distinguishing between benign and malignant lesions. This aligns with previous work demonstrating the value of multimodal approaches for medical image analysis.

Critical Analysis

The researchers acknowledged several limitations of their study. First, the dataset used for training and evaluation, while large, was still relatively homogeneous, being drawn from a few major medical centers. Expanding the dataset to include more diverse, real-world data could help validate the model's performance in a broader range of clinical settings.

Additionally, the researchers did not provide detailed insights into the contribution of each individual expert model or the gating network. Understanding the relative importance of the different MRI modalities and how the model integrates their information could lead to further improvements in the architecture.

Overall, this study presents a promising approach for leveraging multiparametric MRI data to enhance breast cancer diagnosis. However, further research is needed to fully assess the model's generalizability and interpretability, which are crucial for its real-world adoption in clinical practice.

Conclusion

This paper introduces a large machine learning model that uses a mixture of modality-specific experts to improve breast cancer diagnosis from multiparametric MRI data. By combining the specialized knowledge of these experts, the model is able to more effectively leverage the complementary information in different MRI sequences, leading to improved diagnostic performance.

While the study has some limitations, it represents an important step forward in the use of AI for medical image analysis. As the field continues to evolve, similar multimodal approaches may become increasingly valuable for enhancing the accuracy and reliability of clinical decision-making, ultimately leading to better patient outcomes.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Towards Non-invasive and Personalized Management of Breast Cancer Patients from Multiparametric MRI via A Large Mixture-of-Modality-Experts Model
Total Score

0

Towards Non-invasive and Personalized Management of Breast Cancer Patients from Multiparametric MRI via A Large Mixture-of-Modality-Experts Model

Luyang Luo, Mingxiang Wu, Mei Li, Yi Xin, Qiong Wang, Varut Vardhanabhuti, Winnie CW Chu, Zhenhui Li, Juan Zhou, Pranav Rajpurkar, Hao Chen

Breast magnetic resonance imaging (MRI) is the imaging technique with the highest sensitivity for detecting breast cancer and is routinely used for women at high risk. Despite the comprehensive multiparametric protocol of breast MRI, existing artificial intelligence-based studies predominantly rely on single sequences and have limited validation. Here we report a large mixture-of-modality-experts model (MOME) that integrates multiparametric MRI information within a unified structure, offering a noninvasive method for personalized breast cancer management. We have curated the largest multiparametric breast MRI dataset, involving 5,205 patients from three hospitals in the north, southeast, and southwest of China, for the development and extensive evaluation of our model. MOME demonstrated accurate and robust identification of breast cancer. It achieved comparable performance for malignancy recognition to that of four senior radiologists and significantly outperformed a junior radiologist, with 0.913 AUROC, 0.948 AUPRC, 0.905 F1 score, and 0.723 MCC. Our findings suggest that MOME could reduce the need for biopsies in BI-RADS 4 patients with a ratio of 7.3%, classify triple-negative breast cancer with an AUROC of 0.709, and predict pathological complete response to neoadjuvant chemotherapy with an AUROC of 0.694. The model further supports scalable and interpretable inference, adapting to missing modalities and providing decision explanations by highlighting lesions and measuring modality contributions. MOME exemplifies a discriminative, robust, scalable, and interpretable multimodal model, paving the way for noninvasive, personalized management of breast cancer patients based on multiparametric breast imaging data.

Read more

9/4/2024

🔮

Total Score

0

Using Multiparametric MRI with Optimized Synthetic Correlated Diffusion Imaging to Enhance Breast Cancer Pathologic Complete Response Prediction

Chi-en Amy Tai, Alexander Wong

In 2020, 685,000 deaths across the world were attributed to breast cancer, underscoring the critical need for innovative and effective breast cancer treatment. Neoadjuvant chemotherapy has recently gained popularity as a promising treatment strategy for breast cancer, attributed to its efficacy in shrinking large tumors and leading to pathologic complete response. However, the current process to recommend neoadjuvant chemotherapy relies on the subjective evaluation of medical experts which contain inherent biases and significant uncertainty. A recent study, utilizing volumetric deep radiomic features extracted from synthetic correlated diffusion imaging (CDI$^s$), demonstrated significant potential in noninvasive breast cancer pathologic complete response prediction. Inspired by the positive outcomes of optimizing CDI$^s$ for prostate cancer delineation, this research investigates the application of optimized CDI$^s$ to enhance breast cancer pathologic complete response prediction. Using multiparametric MRI that fuses optimized CDI$^s$ with diffusion-weighted imaging (DWI), we obtain a leave-one-out cross-validation accuracy of 93.28%, over 5.5% higher than that previously reported.

Read more

5/14/2024

🖼️

Total Score

0

An updated overview of radiomics-based artificial intelligence (AI) methods in breast cancer screening and diagnosis

Reza Elahi, Mahdis Nazari

Current imaging methods for diagnosing BC are associated with limited sensitivity and specificity and modest positive predictive power. The recent progress in image analysis using artificial intelligence (AI) has created great promise to improve breast cancer (BC) diagnosis and subtype differentiation. In this case, novel quantitative computational methods, such as radiomics, have been developed to improve the sensitivity and specificity of early BC diagnosis and classification. The potential of radiomics in improving the diagnostic efficacy of imaging studies has been shown in several studies. In this review article, we discuss the radiomics workflow and current hand-crafted radiomics methods in the diagnosis and classification of BC based on most recent studies on different imaging modalities, e.g. MRI, mammography, contrast-enhanced spectral mammography (CESM), ultrasound imaging, and digital breast tumosynthesis (DBT). We also discuss current challenges and potential strategies to improve the specificity and sensitivity of radiomics in breast cancer to help achieve a higher level of BC classification and diagnosis in the clinical setting. The growing field of AI incorporation with imaging information has opened a great opportunity to provide a higher level of care for BC patients.

Read more

6/24/2024

🔮

Total Score

0

Improving Breast Cancer Grade Prediction with Multiparametric MRI Created Using Optimized Synthetic Correlated Diffusion Imaging

Chi-en Amy Tai, Alexander Wong

Breast cancer was diagnosed for over 7.8 million women between 2015 to 2020. Grading plays a vital role in breast cancer treatment planning. However, the current tumor grading method involves extracting tissue from patients, leading to stress, discomfort, and high medical costs. A recent paper leveraging volumetric deep radiomic features from synthetic correlated diffusion imaging (CDI$^s$) for breast cancer grade prediction showed immense promise for noninvasive methods for grading. Motivated by the impact of CDI$^s$ optimization for prostate cancer delineation, this paper examines using optimized CDI$^s$ to improve breast cancer grade prediction. We fuse the optimized CDI$^s$ signal with diffusion-weighted imaging (DWI) to create a multiparametric MRI for each patient. Using a larger patient cohort and training across all the layers of a pretrained MONAI model, we achieve a leave-one-out cross-validation accuracy of 95.79%, over 8% higher compared to that previously reported.

Read more

5/14/2024